Ken Anhalt
In addition to MMS, Ken serves on the board of directors of Doppler Veterinary Network. Prior to joining Lindsay Goldberg, Ken worked as an investor at Blackstone in New York and at Bain Capital in Boston.
Ken earned his MBA from Harvard Business School, where he was a George F. Baker Scholar and the recipient of the John L. Loeb finance award, and his A.B. in Economics from Princeton University.
Suggested For You
perspectives
September 3rd, 2025
The State of AI Adoption in Medical Writing
webinar
September 25th, 2025
The Psychedelic Inflection Point: What Sponsors Need to Know Now
news
August 19th, 2025
Friends of Cancer Research and MMS Collaborate to Develop Decision Frameworks for Interim Overall Survival Data in Oncology Trials
perspectives
August 19th, 2025
Career Insights: Shervin Maleki on Data Science and Healthcare Innovation
perspectives
August 12th, 2025
Optimizing Data Management for Oncology Clinical Trials: Design and Technology Best Practices
webinar
August 28th, 2025
Shaping the Future of AI-Enabled Medical Writing
perspectives
August 5th, 2025
Before You Launch Your Next Oncology Trial, Run the Simulation
perspectives
July 29th, 2025
Why Quality by Design Is Still Underused in Emerging Biotech, and What Can Be Done About It
perspectives
July 22nd, 2025
Career Insights: From Military Service to Regulatory Strategy – Ritchie Patton’s Journey at MMS
regulatory intelligence
July 16th, 2025
Navigating the National Priority Review Voucher: Challenges and Solutions
perspectives
July 15th, 2025
Smart AI, Smarter Oversight: What Sponsors Really Need from Their CRO
perspectives
July 8th, 2025
Guidance for Working with External Data Vendors – Getting from LPLV to Database Lock Faster